Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer. | Cancers (Basel) | 2023 | 38067208 | PubTator, text mining | PubMed |
| Significance of circulating tumor cells detection in tumor diagnosis and monitoring. | BMC Cancer | 2023 | 38057833 | PubTator, text mining | PubMed |
| Generation and Characterization of Iduronidase-Cleavable ADCs. | Bioconjug Chem | 2023 | 38054705 | PubTator, text mining | PubMed |
| Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study. | BMC Cancer | 2023 | 38037003 | PubTator, text mining | PubMed |
| The cross-talk between macrophages and tumor cells as a target for cancer treatment. | Front Oncol | 2023 | 38033495 | PubTator, text mining | PubMed |
| Serous Borderline Ovarian Epithelial Type Tumors of Testis in A Young Man with Only Mass Resection: A Case Report. | Iran J Pathol | 2023 | 38024554 | PubTator, text mining | PubMed |
| A bronchial gene signature specific for severe COPD that is retained in the nose. | ERJ Open Res | 2023 | 38020574 | PubTator, text mining | PubMed |
| A mechanistic insight into severe COPD: the nose as a surrogate for the airways. | ERJ Open Res | 2023 | 38020557 | PubTator, text mining | PubMed |
| The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors. | Biomark Res | 2023 | 38017494 | PubTator, text mining | PubMed |
| [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2023 | 38008573 | PubTator, text mining | PubMed |
| Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody-Drug Conjugates. | Cancers (Basel) | 2023 | 38001628 | PubTator, text mining | PubMed |
| Colorectal Liver Metastasis: Can Cytokines Make the Difference? | Cancers (Basel) | 2023 | 38001618 | PubTator, text mining | PubMed |
| Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa. | Cells | 2023 | 37998398 | PubTator, text mining | PubMed |
| SLC35D3 promotes white adipose tissue browning to ameliorate obesity by NOTCH signaling. | Nat Commun | 2023 | 37996411 | PubTator, text mining | PubMed |
| [Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer: A Case Report and Literature Review]. | Zhongguo Fei Ai Za Zhi | 2023 | 37985158 | PubTator, text mining | PubMed |
| Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives. | Clin Transl Med | 2023 | 37983927 | PubTator, text mining | PubMed |
| Analysis of IGFBP7 expression characteristics in pan-cancer and its clinical relevance to stomach adenocarcinoma. | Transl Cancer Res | 2023 | 37969374 | PubTator, text mining | PubMed |
| Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37965453 | PubTator, text mining | PubMed |
| A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno-oncology. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37964753 | PubTator, text mining | PubMed |
| Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy. | Proc Natl Acad Sci U S A | 2023 | 37963244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=16